Zyomyx Announces Issuance of Second Protein Chip Patent
HAYWARD, Calif., April 2 /PRNewswire/ -- Zyomyx, Inc. announced today the U.S. Patent and Trademark Office has issued Zyomyx a patent claiming a broad class of protein immobilization surface configurations having properties ideally suited for attaching proteins to biochip surfaces.
``The state-of-the-art protein chip technology covered in this patent is the second critical element of our emerging broad patent estate,'' said Lawrence Cohen, Ph.D., Zyomyx chief executive officer. ``Together with the 'Non-Specific Binding Resistant Border' technology patent recently issued to Zyomyx, today's patent issuance positions Zyomyx as a dominant player in the protein biochip market by giving broad exclusive rights to key surface chemistry configurations.''
Developed by Peter Wagner, Ph.D., and Steffen Nock, Ph.D., co-founders of Zyomyx, and others, the newly issued patent -- U.S. Patent 6,365,418 -- is entitled ``Arrays of Protein-Capture Agents and Methods of Use Thereof.''
By understanding and engineering the interface between micro-devices and biomolecular assays, Zyomyx will become the leading provider of high throughput, multiplexed protein analysis solutions enabling Zyomyx customers to more rapidly, efficiently, and with minute sample volumes, discover and develop new therapeutic and diagnostic products...
For more information about Zyomyx, please refer to its website at zyomyx.com |
